Single peptide LLGRNSFEV for stimulation of p53 (264-272)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Targeting diseases are cancer, allergies, viral infections and autoimmune disorders.
Purity:
95%
Sequence:
LLGRNSFEV
* VAT and and shipping costs not included. Errors and price changes excepted
